Middle ear fluid Streptococcus pneumoniae serotype distribution in Costa Rican children with otitis media

Adriano Arguedas1, Ron Dagan, Silvia Guevara

  • 1Instituto de Atención Pediátrica, San José, Costa Rica. aarguedas@iped.net

Insights

The heptavalent pneumococcal conjugate vaccine covers 74% of Streptococcus pneumoniae causing otitis media in Costa Rican children. Serotype distribution in pediatric middle ear fluid is similar to developed countries.

Area of Science:

  • Pediatric infectious diseases
  • Microbiology
  • Vaccinology

Background:

  • Streptococcus pneumoniae conjugate vaccine introduced in Costa Rica in 2004.
  • Previous data (1999-2001) showed serotype 19F prevalence at 75% in pediatric middle ear fluid (MEF).
  • Recent shifts in prevalent serotypes necessitate updated epidemiological data.

Purpose of the Study:

  • Identify common S. pneumoniae serotypes in MEF of Costa Rican children with otitis media (OM).
  • Analyze serotype distribution by demographics, disease characteristics, and antimicrobial susceptibility.
  • Assess the coverage of the heptavalent S. pneumoniae conjugate vaccine for OM in this population.

Main Methods:

  • Collected 69 S. pneumoniae isolates from MEF of children (3-49 months) with OM in 2002-2003.
  • Performed serotyping using the quellung reaction with Statens Serum Institute antisera.

Main Results:

  • Most common serotypes: 19F (26.1%), 6B (14.5%), 9V (8.7%), 16F (8.7%), 14 (5.8%), 23F (5.8%), 3 (5.8%), and 6A (5.8%).
  • Serotype distribution showed no significant differences based on age or disease distribution.
  • A trend indicated higher non-susceptibility to penicillin and trimethoprim-sulfamethoxazole among vaccine-type strains.

Conclusions:

  • S. pneumoniae serotype distribution causing pediatric OM in Costa Rica resembles that of developed nations.
  • The current heptavalent pneumococcal conjugate vaccine is estimated to cover 74% of OM cases in Costa Rican children.
Abstract

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...